
Sign up to save your podcasts
Or


New medicines with sales in the billions of dollars each year are what every pharmaceutical company dreams of, but how do you create one and can they really justify their often high price tags?
Evan Davis and guests discuss the changing origins of so-called 'blockbusters' and their importance to the global drug industry, including recent examples like the obesity and diabetes treatments Wegovy and Ozempic, which have made Novo Nordisk one of the richest companies in Europe.
Plus, as outright cures for some diseases begin to emerge, how can the pharmaceutical industry and healthcare systems agree on what is a reasonable price to pay for them?
Evan is joined by:
Sir Patrick Vallance, former president of research and development at GSK, chief scientific advisor to the UK government, now chair of the Natural History Museum;
PRODUCTION TEAM:
Producer: Simon Tulett
(Picture: Rolls of dollar bills next to a bottle of pills. Credit: Getty Images)
By BBC Radio 44.7
3232 ratings
New medicines with sales in the billions of dollars each year are what every pharmaceutical company dreams of, but how do you create one and can they really justify their often high price tags?
Evan Davis and guests discuss the changing origins of so-called 'blockbusters' and their importance to the global drug industry, including recent examples like the obesity and diabetes treatments Wegovy and Ozempic, which have made Novo Nordisk one of the richest companies in Europe.
Plus, as outright cures for some diseases begin to emerge, how can the pharmaceutical industry and healthcare systems agree on what is a reasonable price to pay for them?
Evan is joined by:
Sir Patrick Vallance, former president of research and development at GSK, chief scientific advisor to the UK government, now chair of the Natural History Museum;
PRODUCTION TEAM:
Producer: Simon Tulett
(Picture: Rolls of dollar bills next to a bottle of pills. Credit: Getty Images)

7,707 Listeners

369 Listeners

873 Listeners

1,054 Listeners

52 Listeners

43 Listeners

5,538 Listeners

1,795 Listeners

1,818 Listeners

1,085 Listeners

2,105 Listeners

1,957 Listeners

722 Listeners

55 Listeners

236 Listeners

69 Listeners

111 Listeners

732 Listeners

163 Listeners

3,216 Listeners

1,594 Listeners

3,566 Listeners

802 Listeners

196 Listeners

49 Listeners